208720-71-2

Basic information

• Product Name: OseltaMivir Acid Methyl Ester
• Synonyms: OseltaMivir Acid Methyl Ester;(3R,4R,5S)-4-(AcetylaMino)-5-aMino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic Acid Methyl Ester;Methyl (3R,4R,5S)-4-(AcetylaMino)-5-aMino-3-(1-ethylpropoxy)- 1-cyclohexene-1-carboxyate;Oseltamivir Methyl Ester;Oseltamivir EP Impurity E;(3R,4R,5S)-ethyl 4-acetamido-5-(allylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate;(3R,4R,5S)-methyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate;Oseltamivir Phosphate impurity E (EP)
• CAS NO: 208720-71-2
• Molecular Formula: C15H26N2O4
• Molecular Weight: 298.37794
• Product Categories: Amines;Anti-virals;Impurities;Intermediates & Fine Chemicals;Pharmaceuticals
• Mol File: 208720-71-2.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 462.1±45.0 °C(Predicted)
• Appearance: /
• Density: 1.10±0.1 g/cm3(Predicted)
• Storage Temp.: Hygroscopic, -20°C Freezer, Under inert atmosphere
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• PKA: 14.65±0.70(Predicted)
• Stability: Hygroscopic
• CAS DataBase Reference: OseltaMivir Acid Methyl Ester(CAS DataBase Reference)
• NIST Chemistry Reference: OseltaMivir Acid Methyl Ester(208720-71-2)
• EPA Substance Registry System: OseltaMivir Acid Methyl Ester(208720-71-2)

Safety Data

• Hazardous Substances Data: 208720-71-2(Hazardous Substances Data)

Usage

Uses

Oseltamivir EP Impurity E It is a COVID19-related research product.

Upstream product

• 187227-22-1 (1S,5S,6S)-5-Azido-7-trityl-7-aza-bicyclo[4.1.0]hept-2-ene-3-carboxylic acid methyl ester 
• 187226-95-5 (3R,4R,5S)-4-Amino-5-azido-3-methoxymethoxy-cyclohex-1-enecarboxylic acid methyl ester 
• 187226-91-1 (3R,4S,5R)-5-Azido-4-methanesulfonyloxy-3-methoxymethoxy-cyclohex-1-enecarboxylic acid methyl ester 
• 187226-89-7 (3R,4S,5R)-5-Azido-4-hydroxy-3-methoxymethoxy-cyclohex-1-enecarboxylic acid methyl ester 
• 187226-97-7 (3R,4R,5S)-4-Acetylamino-5-azido-3-methoxymethoxy-cyclohex-1-enecarboxylic acid methyl ester 
• 187226-93-3 (1R,5R,6R)-5-Methoxymethoxy-7-aza-bicyclo[4.1.0]hept-3-ene-3-carboxylic acid methyl ester 
• 67-56-1 methanol 
• 196618-13-0 oseltamivir 

Relevant articles and documents

Novel compound, its synthetic method and therapeutic use (by machine translation)

Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.